Market Overview:
The global cannabis-based medicines market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing legalization of cannabis for medical purposes, rising awareness about the benefits of cannabis-based medicines, and growing demand for alternative treatment options. On the basis of application, the global cannabis-based medicines market is divided into oral solution, tablets/capsules, patches/transdermal products,, and others. The oral solution segment is anticipated to hold a dominant position in terms of revenue share in 2018 owing to its high adoption rate among patients suffering from various medical conditions such as cancer pain relief,, chronic pain management,, multiple sclerosis,, etc.
Product Definition:
Cannabis-based medicines are medications that are made from extracts of the Cannabis plant. They are used to treat a variety of medical conditions, including cancer, multiple sclerosis, and chronic pain. The importance of cannabis-based medicines is that they offer an alternative to traditional medications for treating these conditions.
CBD (Cannabidiol) Based:
Cannabidiol (CBD) based medicines are gaining significant traction in the global market. In addition, these products are considered safe for consumption even by non-medical users.
The cannabis plant has been used for recreational and medical purposes throughout its history.
THC (Tetrahydrocannabinol) Based:
The growing number of countries legalizing the medical use of marijuana is expected to be a major factor driving the industry growth over the forecast period. For instance, Germany has legalized medical marijuana production for patients suffering from AIDS, cancer and other diseases; additionally, Israel has approved the import of cannabis for therapeutic purposes.
Application Insights:
Based on application, the market is segmented into oral solution, patches, tablets, and others. The oral solution segment dominated the overall cannabis-based medicines market in 2017 owing to its non-intrusive nature. This allows patients to self-administer the medicine and reduces healthcare professionals¢â‚¬â„¢ time consumption. Furthermore, this segment is expected to grow at a lucrative rate over the forecast period owing to increasing awareness about medical marijuana among patients suffering from chronic pain or illness.
The patch segment is expected witness significant growth during the forecast period due largely to its non-psychoactive properties that allow people who consume it for medicinal purposes avoid getting high like other forms of cannabis do.
Regional Analysis:
North America dominated the market in 2017 owing to the presence of major companies such as GW Pharmaceuticals, CV Sciences, and MedReleaf. The region is expected to maintain its dominance over the forecast period due to increasing R&D activities related to cannabis-based medicines. In addition, growing legalization of marijuana for medical and recreational purposes is also anticipated to drive growth in this region. For instance, on November 8th 2018; Canada legalized marijuana for recreational use which will expand market reach across this region.
Europe accounted for a significant share in terms of revenue generation owing to factors such as favorable government regulations pertaining towards medicinal cannabis products.
Growth Factors:
- Increasing legalization of cannabis for medical purposes across the globe.
- Growing research on therapeutic potential of cannabis and its derivatives.
- Rising demand for alternative treatment options for various diseases and disorders.
- Technological advancements in cannabis extraction and purification processes.
- Growing awareness about benefits of cannabis-based medicines among healthcare professionals and consumers
Scope Of The Report
Report Attributes
Report Details
Report Title
Cannabis-based Medicines Market Research Report
By Type
CBD (Cannabidiol) Based, THC (Tetrahydrocannabinol) Based, Others
By Application
Oral Solution, Tablets, Patches, Others
By Companies
GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, Axim Biotechnologies, Revive Therapeutics, MGC Pharmaceuticals, ECHO Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Cannabis-based Medicines Market Report Segments:
The global Cannabis-based Medicines market is segmented on the basis of:
Types
CBD (Cannabidiol) Based, THC (Tetrahydrocannabinol) Based, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oral Solution, Tablets, Patches, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GW Pharmaceuticals plc
- INSYS Therapeutics
- Aequus Pharmaceuticals
- Axim Biotechnologies
- Revive Therapeutics
- MGC Pharmaceuticals
- ECHO Pharmaceuticals
Highlights of The Cannabis-based Medicines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CBD (Cannabidiol) Based
- THC (Tetrahydrocannabinol) Based
- Others
- By Application:
- Oral Solution
- Tablets
- Patches
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cannabis-based Medicines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cannabis-based medicines are medications that contain cannabinoids, including THC and CBD. These substances interact with the body in a way that can provide relief from symptoms.
Some of the major companies in the cannabis-based medicines market are GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, Axim Biotechnologies, Revive Therapeutics, MGC Pharmaceuticals, ECHO Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cannabis-based Medicines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cannabis-based Medicines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cannabis-based Medicines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cannabis-based Medicines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cannabis-based Medicines Market Size & Forecast, 2018-2028
4.5.1 Cannabis-based Medicines Market Size and Y-o-Y Growth
4.5.2 Cannabis-based Medicines Market Absolute $ Opportunity
Chapter 5 Global Cannabis-based Medicines Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cannabis-based Medicines Market Size Forecast by Type
5.2.1 CBD (Cannabidiol) Based
5.2.2 THC (Tetrahydrocannabinol) Based
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cannabis-based Medicines Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cannabis-based Medicines Market Size Forecast by Applications
6.2.1 Oral Solution
6.2.2 Tablets
6.2.3 Patches
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cannabis-based Medicines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cannabis-based Medicines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cannabis-based Medicines Analysis and Forecast
9.1 Introduction
9.2 North America Cannabis-based Medicines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cannabis-based Medicines Market Size Forecast by Type
9.6.1 CBD (Cannabidiol) Based
9.6.2 THC (Tetrahydrocannabinol) Based
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cannabis-based Medicines Market Size Forecast by Applications
9.10.1 Oral Solution
9.10.2 Tablets
9.10.3 Patches
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cannabis-based Medicines Analysis and Forecast
10.1 Introduction
10.2 Europe Cannabis-based Medicines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cannabis-based Medicines Market Size Forecast by Type
10.6.1 CBD (Cannabidiol) Based
10.6.2 THC (Tetrahydrocannabinol) Based
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cannabis-based Medicines Market Size Forecast by Applications
10.10.1 Oral Solution
10.10.2 Tablets
10.10.3 Patches
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cannabis-based Medicines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cannabis-based Medicines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cannabis-based Medicines Market Size Forecast by Type
11.6.1 CBD (Cannabidiol) Based
11.6.2 THC (Tetrahydrocannabinol) Based
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cannabis-based Medicines Market Size Forecast by Applications
11.10.1 Oral Solution
11.10.2 Tablets
11.10.3 Patches
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cannabis-based Medicines Analysis and Forecast
12.1 Introduction
12.2 Latin America Cannabis-based Medicines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cannabis-based Medicines Market Size Forecast by Type
12.6.1 CBD (Cannabidiol) Based
12.6.2 THC (Tetrahydrocannabinol) Based
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cannabis-based Medicines Market Size Forecast by Applications
12.10.1 Oral Solution
12.10.2 Tablets
12.10.3 Patches
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cannabis-based Medicines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cannabis-based Medicines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cannabis-based Medicines Market Size Forecast by Type
13.6.1 CBD (Cannabidiol) Based
13.6.2 THC (Tetrahydrocannabinol) Based
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cannabis-based Medicines Market Size Forecast by Applications
13.10.1 Oral Solution
13.10.2 Tablets
13.10.3 Patches
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cannabis-based Medicines Market: Competitive Dashboard
14.2 Global Cannabis-based Medicines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GW Pharmaceuticals plc
14.3.2 INSYS Therapeutics
14.3.3 Aequus Pharmaceuticals
14.3.4 Axim Biotechnologies
14.3.5 Revive Therapeutics
14.3.6 MGC Pharmaceuticals
14.3.7 ECHO Pharmaceuticals
